D
Denali Therapeutics
South San Francisco, United States
Founded 2015 NASDAQ: DNLI
Nanomedicine Drug Delivery Protein Nanoparticles Nano-Bio Gene Therapy Delivery Regenerative Medicine
About
Neurodegeneration drugs using Transport Vehicle BBB-crossing technology
Company Details
- Type
- public
- Employees
- 600+
- Funding
- Public
Key Products
- TV Platform
- Neurodegeneration Drugs